哈三联 (002900)

HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.

ASZ

Tags

Generic DrugsInnovative DrugsMedical Aesthetics ConceptPharmaceutical ManufacturingPet Economy

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 31635.76
  • Circulating A-Shares(W): 17495.36
  • Earnings Per Share(RMB): -0.6600
  • Net Assets Per Share(RMB): 6.0172
  • Operating Revenue(W RMB): 58064.91
  • Total Profit(W RMB): -22585.78
  • Net Profit Attributable to Parent(W RMB): -20884.16
  • Net Profit Growth Rate(%): -614.61
  • Weighted Return on Equity(%): -10.2900
  • Operating Cash Flow Per Share(RMB): 0.0870
  • Undistributed Profit Per Share(RMB): 1.0628
  • Capital Reserve Per Share(RMB): 3.4541

2. Main Business

The main business covers:

  • Research, development, production, and sales of chemical pharmaceutical preparations.

3. Company Basic Information

  • Company Name: Harbin Medisan Pharmaceutical Co., Ltd.
  • Listing Date: 2017-09-22
  • Industry: Pharmaceutical Manufacturing
  • Address: Beijing Road, Limin Development Zone, Harbin City, Heilongjiang Province
  • Website: www.medisan.com.cn
  • Company Profile：The company was established as a joint stock company through the legal overall change based on Harbin Sanlian Pharmaceutical Co., Ltd. According to the resolution passed at the shareholders' meeting of Sanlian Co., Ltd. on December 23, 2013, Sanlian Co., Ltd. was transformed into a joint stock company. Based on the audited net assets of 355,574,800 yuan as of November 30, 2013, 150,000,000 yuan was converted into 150,000,000 shares of the company's capital stock, and the remaining portion of the net assets was included in capital reserve. The registered capital after the change was 150,000,000 yuan. Shanghai Dongzhou Asset Appraisal Co., Ltd. appraised the net assets of Sanlian Co., Ltd. as of November 30, 2013 and issued the "Appraisal Report for the Project of Harbin Sanlian Pharmaceutical Co., Ltd. Intending to Change into a Joint Stock Company" (Hu Dongzhou Zi Ping Bao Zi [2013] No. 0935231). As of the appraisal base date, the appraised value of Sanlian Co., Ltd.'s net assets was 438,850,700 yuan. On December 27, 2013, Sanlian Pharmaceutical was registered and established at the Harbin Administration for Industry and Commerce, obtaining the "Business License of Enterprise Legal Person" with registration number 230100400002133.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Harbin Limin Shengde Development Co., Ltd. General Legal Person 1237.50 7.15
2 Baring Capital Limited - Baring Emerging Markets Small and Medium Enterprise Fund (USA) Asset Management Plan 194.82 1.13
3 CITIC Securities Asset Management (Hong Kong) Limited - Client Funds Asset Management Plan 72.05 0.42
4 UBS AG QFII 55.29 0.32

5. Concept Sectors

  • Generic Drugs
  • Medical Aesthetics Concept
  • Innovative Drugs
  • Pet Economy

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information